BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Behle N, Kamp F, Proebstl L, Hager L, Riebschläger M, Schacht-Jablonowsky M, Hamdorf W, Neumann S, Krause D, Manz K, Franke AG, Koller G, Soyka M. Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users. World J Psychiatry 2022; 12(7): 944-957 [PMID: 36051595 DOI: 10.5498/wjp.v12.i7.944]
URL: https://www.wjgnet.com/2220-3206/full/v12/i7/944.htm
Number Citing Articles
1
Jennifer M. Loftis, Sankrith Ramani, Evan J. Firsick, Rebekah Hudson, Anh Le-Cook, Kevin S. Murnane, Arthur Vandenbark, Renee L. Shirley. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamineFrontiers in Psychiatry 2023; 14 doi: 10.3389/fpsyt.2023.1259041
2
Yanan Zhou, Winson Fu Zun Yang, Qiuxia Wu, Yuejiao Ma, Jun Zhou, Honghong Ren, Yuzhu Hao, Manyun Li, Yunfei Wang, Pu Peng, Ning Yuan, Yifan Xiong, Yizhuo Wang, Qianjin Wang, Tieqiao Liu. Altered spontaneous neurological activity in methamphetamine use disorders and its association with cognitive functionAsian Journal of Psychiatry 2024; 94: 103936 doi: 10.1016/j.ajp.2024.103936
3
Taylor Zande, Albert Kopak, Norman Hoffmann. Multiple diagnoses in the context of parallel epidemics: methamphetamine, opioid use disorder and psychiatric conditionsJournal of Public Mental Health 2024; 23(1): 4 doi: 10.1108/JPMH-09-2023-0076
4
Sercan Karabulut. A 6-Month Follow-Up Study: Cognitive Impairment May Predict More Frequent Use of MethamphetamineSubstance Abuse: Research and Treatment 2023; 17: 117822182311758 doi: 10.1177/11782218231175811